4[4]Monsonego A,Weiner HL.Immunotherapeutic approaches to Alzheimer's disease[J].Science,2003,302(5646):834-838.
5[5]Frostegard J.Autoimmunity,oxidized LDL and cardiovascular disease[J].Autoimmun Rev,2002,1(4):233-237.
6[6]Zhou X,Caligiuri G,Hamsten A,et al.LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis[J].Arterioscler Thromb Vase Biol,2001,21(1):108-114.
7[7]Freigang S,Horkko S,Miller E,et al.Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes[J].Arterioscler Thromb Vasc Biol,1998,18(12):1972-1982.
8[8]Reardon CA,Miller ER,Blaehowicz L,et al.Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice[J].J Lipid Res,2004,45(7):1347-1354.
9[9]Fredrikson GN,Hedblad B,Berglund G,et al.Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease[J].Arterioseler Thromb Vase Biol,2003,23(5):872-878.
10[10]Fredrikson GN,Soderberg I,Lindholm M,et al.Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences[J].Arterioscler Thromb Vasc Biol,2003,23(5):879-884.
